Melbourne, Nov 10 (IANS) Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol and triglycerides in people with difficult-to-treat lipid disorders.
The trial tested CTX310, a one-…
